دورية أكاديمية
Cysteinyl-leukotrienes promote cutaneous Leishmaniasis control.
| العنوان: | Cysteinyl-leukotrienes promote cutaneous Leishmaniasis control. |
|---|---|
| المؤلفون: | Noronha LPT; Laboratory of Immunophysiology, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Martins MDA; Laboratory of Immunophysiology, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Castro-Junior AB; Laboratory of Immunophysiology, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Thorstenberg ML; Laboratory of Immunophysiology, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Costa-Soares L; Laboratory of Immunophysiology, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Rangel TP; Laboratory of Immunophysiology, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Carvalho-Gondim F; Laboratory of Immunopharmacology, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Rossi-Bergmann B; Laboratory of Immunopharmacology, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Savio LEB; Laboratory of Immunophysiology, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Canetti CA; Laboratory of Inflammation, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Coutinho-Silva R; Laboratory of Immunophysiology, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. |
| المصدر: | Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2023 Jun 12; Vol. 13, pp. 1192800. Date of Electronic Publication: 2023 Jun 12 (Print Publication: 2023). |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Lausanne : Frontiers Media SA |
| مواضيع طبية MeSH: | Leishmaniasis, Cutaneous*/drug therapy , Leishmaniasis*/pathology, Mice ; Animals ; Mice, Inbred C57BL ; Leukotrienes/physiology ; Cysteine ; Leukotriene B4 |
| مستخلص: | Leishmaniasis is a neglected tropical parasitic disease with few approved medications. Cutaneous leishmaniasis (CL) is the most frequent form, responsible for 0.7 - 1.0 million new cases annually worldwide. Leukotrienes are lipid mediators of inflammation produced in response to cell damage or infection. They are subdivided into leukotriene B4 (LTB Competing Interests: The authors declare that the research was conducted without commercial or financial relationships that could be construed as potential conflicts of interest. (Copyright © 2023 Noronha, Martins, Castro-Junior, Thorstenberg, Costa-Soares, Rangel, Carvalho-Gondim, Rossi-Bergmann, Savio, Canetti and Coutinho-Silva.) |
| References: | Cell Microbiol. 2011 Sep;13(9):1410-28. (PMID: 21740498) PLoS Pathog. 2019 Jun 24;15(6):e1007887. (PMID: 31233552) J Immunol. 2005 Jan 15;174(2):589-94. (PMID: 15634873) Proc Natl Acad Sci U S A. 1981 Jun;78(6):3887-91. (PMID: 6267608) An Bras Dermatol. 2014 Jan-Feb;89(1):52-8. (PMID: 24626648) J Immunol. 2006 Sep 1;177(5):3201-8. (PMID: 16920959) Parasit Vectors. 2016 Sep 05;9(1):489. (PMID: 27595742) J Immunol. 2006 Apr 1;176(7):4440-8. (PMID: 16547282) Mol Biochem Parasitol. 1985 Apr;15(1):1-10. (PMID: 2859521) Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):517-21. (PMID: 7831322) J Immunol. 2023 Feb 1;210(3):221-227. (PMID: 36649580) Front Cell Infect Microbiol. 2012 Sep 19;2:121. (PMID: 23050244) Am J Physiol Cell Physiol. 2020 May 1;318(5):C832-C835. (PMID: 32159362) Int Arch Allergy Immunol. 2009;149(3):275-82. (PMID: 19218821) Purinergic Signal. 2018 Jun;14(2):201-211. (PMID: 29680937) Front Immunol. 2018 Jul 09;9:1531. (PMID: 30038612) Blood. 2012 Mar 29;119(13):3113-22. (PMID: 22323449) Br J Pharmacol. 2002 Dec;137(8):1339-45. (PMID: 12466244) J Immunol. 2014 May 15;192(10):4765-73. (PMID: 24729618) Parasite Immunol. 1985 Sep;7(5):545-55. (PMID: 3877902) Respir Med. 2011 May;105(5):667-73. (PMID: 21169002) Comp Immunol Microbiol Infect Dis. 2004 Sep;27(5):305-18. (PMID: 15225981) Front Pharmacol. 2018 Feb 06;9:52. (PMID: 29467654) J Pharmacol Sci. 2009 Feb;109(2):285-92. (PMID: 19234368) Med Res Rev. 2007 Jul;27(4):469-527. (PMID: 16894531) Allergol Int. 2008 Dec;57(4):291-8. (PMID: 18797182) N Engl J Med. 1990 Dec 20;323(25):1736-9. (PMID: 2174121) Microbes Infect. 2009 Sep;11(10-11):842-9. (PMID: 19439191) Lancet. 2018 Sep 15;392(10151):951-970. (PMID: 30126638) Biochem J. 2007 Aug 1;405(3):379-95. (PMID: 17623009) |
| فهرسة مساهمة: | Keywords: LTC4; LTD4; Leishmania amazonensis; P2X7; cutaneous leishmaniasis (CL); cysteinyl-leukotrienes |
| المشرفين على المادة: | 0 (cysteinyl-leukotriene) 0 (Leukotrienes) K848JZ4886 (Cysteine) 1HGW4DR56D (Leukotriene B4) |
| تواريخ الأحداث: | Date Created: 20230628 Date Completed: 20230630 Latest Revision: 20230703 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC10291179 |
| DOI: | 10.3389/fcimb.2023.1192800 |
| PMID: | 37377641 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2235-2988 |
|---|---|
| DOI: | 10.3389/fcimb.2023.1192800 |